CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4 Open-market sale Chief Medical Officer sold 2,981 shares at $7.85 ($23,401)
- 4 Open-market sale President and CEO sold 11,451 shares at $7.85 ($89,890)
- 4 Open-market sale Francis Chris sold 2,708 shares at $7.85 ($21,258)
- 4 Open-market sale Senior VP, Drug Discovery sold 3,188 shares at $7.85 ($25,026)
- 4 Open-market sale Interim CFO sold 651 shares at $7.00 ($4,557)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Senior VP, Drug Discovery sold 6,000 shares at $35.00 ($210,000)
- 4 Open-market sale Director sold 30,039 shares at an average $30.63 ($920,213)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 14 · 274 filings